Pages that link to "Item:Q5295377"
From MaRDI portal
The following pages link to Augmented Designs to Assess Immune Response in Vaccine Trials (Q5295377):
Displaying 18 items.
- Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy (Q2001894) (← links)
- Identification of causal effects within principal strata using auxiliary variables (Q2075703) (← links)
- Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption (Q2170431) (← links)
- Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model (Q2482986) (← links)
- Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials (Q2846433) (← links)
- Surrogate Measures and Consistent Surrogates (Q2861938) (← links)
- Comparing Biomarkers as Principal Surrogate Endpoints (Q2893405) (← links)
- Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials (Q3076045) (← links)
- Augmented Designs to Assess Principal Strata Direct Effects (Q3107200) (← links)
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
- Incorporating founder virus information in vaccine field trials (Q3459936) (← links)
- Evaluating Candidate Principal Surrogate Endpoints (Q3549407) (← links)
- A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint (Q4649074) (← links)
- A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework (Q4984852) (← links)
- Assessing Vaccine Effects in Repeated Low‐Dose Challenge Experiments (Q5850972) (← links)
- A unified evaluation of differential vaccine efficacy (Q6047741) (← links)
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy (Q6055756) (← links)
- Assurance in vaccine efficacy clinical trial design based on immunological responses (Q6085899) (← links)
